Paper Details

  1. Home
  2. Paper Details

Ribociclib-Induced Pneumonitis: A Case Report.

Author: Al-TweigeriTaher, AlgwaizGhada, BadranAhmed Ali, ElshenawyMahmoud A

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors are effective in treating hormone receptor-positive, HER2-negative metastatic breast cancer, but they can cause side effects such as myelosuppression, mucositis, fatigue, gastrointestinal issues, hepatic toxicities, and QTc prolongation.
Paper Details　
Original Abstract of the Article :
Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have been a significant breakthrough in the management of hormone receptor-positive, HER2-negative metastatic breast cancer based on the results of several large phase III randomized trials. The most common reported toxicity is myelosuppression due to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248782/

データ提供：米国国立医学図書館（NLM）

Ribociclib-Induced Pneumonitis: A Case Report

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors, like a powerful tool in the desert, offer hope for patients battling metastatic breast cancer. This research, a detailed case report, investigates a rare but potentially serious side effect of ribociclib, a CDK 4/6 inhibitor, known as pneumonitis, a condition that can feel like a suffocating sandstorm.

Navigating the Side Effects of Cancer Treatment: A Case of Ribociclib-Induced Pneumonitis

This case report, like a single footprint in the desert, highlights the importance of ongoing vigilance and comprehensive monitoring during cancer treatment. While CDK 4/6 inhibitors have shown promise in treating breast cancer, this research underscores the need for awareness of potential side effects and prompt intervention when necessary. This case study serves as a reminder that even with the most beneficial treatments, there can be unforeseen consequences.

Understanding the Risks and Benefits: A Journey Through Cancer Treatment

This research provides valuable insight into the potential risks and benefits of CDK 4/6 inhibitors. It emphasizes the importance of careful monitoring and open communication between patients and their healthcare providers. This study encourages a collaborative approach to cancer treatment, ensuring that patients are informed about potential side effects and empowered to make informed decisions about their care.

Dr. Camel's Conclusion

This case report, like a solitary dune in the desert, reminds us that even with the most advanced treatments, there can be unexpected side effects. This research underscores the importance of careful monitoring and open communication between patients and their healthcare providers, ensuring a safe and informed journey through cancer treatment.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-07
Further Info :

Pubmed ID

34248473

DOI: Digital Object Identifier

PMC8248782

Related Literature

Article Analysis
・Side Effects of ribociclib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.